Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was founded in 2006 and is headquartered in Waltham, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Viridian Therapeutics Inc..
Viridian Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Viridian Therapeutics Inc. are also analyzed.
Detailed
SWOT Analysis of the company including key strengths and weaknesses of Viridian Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Viridian Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Viridian Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Viridian Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Viridian Therapeutics Inc.- Key Facts
2.2 Viridian Therapeutics Inc.- Geographic Locations
2.3 Viridian Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Viridian Therapeutics Inc.- Business Divisions
2.5 Viridian Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Viridian Therapeutics Inc. Strategic Analysis Review
3.1 Viridian Therapeutics Inc.- Key Strategies
3.2 Viridian Therapeutics Inc.- Company Outlook Statement
3.3 Viridian Therapeutics Inc.- SWOT Analysis
3.3.1 Viridian Therapeutics Inc.- Key Strengths
3.3.2 Viridian Therapeutics Inc.- Key Weaknesses
3.3.3 Viridian Therapeutics Inc.- Potential Opportunities
3.3.4 Viridian Therapeutics Inc.- Potential Threats
3.4 Viridian Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Viridian Therapeutics Inc.- Business Overview
4.2 Viridian Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Viridian Therapeutics Inc.- Key Products
5.2 Viridian Therapeutics Inc.- Key Service Areas
5.3 Viridian Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Viridian Therapeutics Inc.- Company History
6.2 Viridian Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Viridian Therapeutics Inc.- Income Statements
7.2 Viridian Therapeutics Inc.- Balance Sheet
7.3 Viridian Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Viridian Therapeutics Inc.- Direct Competitors
8.2 Viridian Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Viridian Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Viridian Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!